Corona Virus Vaccine China expected to produce about 600 million times by the end of the year September 26 at 10:14 p.m.
The Chinese government said four vaccines for the new coronavirus, which Chinese pharmaceutical companies and others are developing, are in the final stages of clinical trials and are expected to be able to produce about 600 million vaccines by the end of the year.
At a press conference today, Liu Engo, director of China’s Ministry of Science and Technology, said that “development is going well” after revealing that 11 vaccines have been conducted and four of them are in the final stages.
Final clinical trials are conducted outside the country, and two vaccines under the development of “Chinese biological technology” under the umbrella of a state-owned company have been given to more than 35,000 people in the Middle East, and no noticeable problems have occurred.
In addition, the vaccine of the pharmaceutical company “Sinoback” is in South America and Southeast Asia, and the vaccine developed jointly by “Kansino Biologics” and the Research Institute of the People’s Liberation Army is conducting the final stage clinical trial in Asia and Europe respectively.
As for the phenomenon called ADE, “antibody-dependent infection enhancement,” in which vaccines rather increase the infection and proliferation of the virus, experts who attended said it was “not confirmed so far.”
In addition, Tadahide Tsuji, chief of the National Health and Health Commission, said he expected to be able to produce 610 million vaccines by the end of this year and more than a billion times next year.
The reason for the appeal that the development of vaccines is progressing smoothly is that the company wants to strengthen its international influence.